4//SEC Filing
Lentini Renee 4
Accession 0001415889-24-002870
CIK 0000855654other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 9:41 PM ET
Size
8.9 KB
Accession
0001415889-24-002870
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
Lentini Renee
V.P.-Fin., Prin. Acctg. Off.
Transactions
- Sale
Common Stock
2024-02-05$29.30/sh−2,631$77,088→ 14,723 total - Exercise/Conversion
Common Stock
2024-02-02+8,435→ 17,354 total - Exercise/Conversion
Restricted Stock Unit
2024-02-02−8,435→ 16,870 totalExercise: $0.00→ Common Stock (8,435 underlying)
Footnotes (3)
- [F1]Effected pursuant to a trading plan adopted on June 6, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
- [F3]The RSUs were granted on 2/3/2023 and vest over a three-year period, with 33 1/3% of the RSUs vesting on each of the first three anniversaries of the date of grant, subject to continued service through each vesting date.
Documents
Issuer
ImmunoGen, Inc.
CIK 0000855654
Entity typeother
Related Parties
1- filerCIK 0001838777
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 9:41 PM ET
- Size
- 8.9 KB